Alicanto expands functionality for virtual tumor boards and clininical trials

Alicanto™ is a social learning platform developed by Yuri Quintana that supports online communities of practice and the learning health system. Alicanto is being used at BIDMC for cancer clinical collaborations across an extensive hospital network https://www.alicantobidmc.org.
Recently, Alicanto has added new tools to support group collaboration for online virtual tumor boards and managing clinical trials. For more information, contact Yuri Quintana, Ph.D. at yquintan@bidmc.harvard.edu.

Alicanto Use Cases